Literature DB >> 21429567

Fibrin formation is more impaired than thrombin generation and platelets immediately following cardiac surgery.

Cristina Solomon1, Niels Rahe-Meyer, Benny Sørensen.   

Abstract

INTRODUCTION: Cardiac surgery performed on cardio-pulmonary bypass (CPB) may be complicated by coagulopathy and bleeding. This prospective observational study investigated the CPB-induced changes in thrombin generation, fibrin formation, and in the platelet component of the whole blood clot elasticity. The effects of haemostatic therapy with fresh frozen plasma (FFP) and platelet concentrate on these parameters were also evaluated.
MATERIALS AND METHODS: In 90 cardiac surgery patients, thrombin generation was measured using the calibrated automated thrombogram, fibrin formation was assessed as the maximum clot elasticity of the fibrin-based clot in the thromboelastometry FIBTEM test (MCE(FIBTEM)), and the platelet component was defined as the difference in maximum elasticity between the whole blood clot obtained through extrinsic activation and the fibrin-based clot (MCE(EXTEM)-MCE(FIBTEM)). Blood samples were collected before surgery, immediately after CPB, and after administration of FFP or FFP and platelet concentrate.
RESULTS: Following CPB, the endogenous thrombin potential decreased to 93%, from median 1485 (interquartile range 1207, 1777) to 1382 (1190, 1533) nM*min (P>0.05), MCE(FIBTEM) decreased to 62%, from 21 (19, 29) to 14 (12, 19) (P<0.001), and the platelet component to 73%, from 139 (119, 174) to 101 (87, 121) (P<0.001). Administration of 11 (10, 13) ml per kg of bodyweight (ml/kgbw) FFP (40 patients), or of 13 (10, 18) ml/kgbw FFP and 7 (5, 9) ml/kgbw platelet concentrate (18 patients) brought no statistically significant changes in these parameters.
CONCLUSIONS: Fibrin formation is more impaired than thrombin generation and the platelet component of the whole blood clot immediately after cardiopulmonary bypass.
Copyright © 2011. Published by Elsevier Ltd.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21429567     DOI: 10.1016/j.thromres.2011.02.022

Source DB:  PubMed          Journal:  Thromb Res        ISSN: 0049-3848            Impact factor:   3.944


  13 in total

1.  Fibrinogen concentrate as first-line therapy in aortic surgery reduces transfusion requirements in patients with platelet counts over or under 100×10(9)/L.

Authors:  Cristina Solomon; Niels Rahe-Meyer
Journal:  Blood Transfus       Date:  2014-10-23       Impact factor: 3.443

2.  Three-factor prothrombin complex concentrates for refractory bleeding after cardiovascular surgery within an algorithmic approach to haemostasis.

Authors:  Nazish K Hashmi; Kamrouz Ghadimi; Amudan J Srinivasan; Yi-Ju Li; Robert D Raiff; Jeffrey G Gaca; Adam G Root; Yaron D Barac; Thomas L Ortel; Jerrold H Levy; Ian J Welsby
Journal:  Vox Sang       Date:  2019-04-02       Impact factor: 2.144

3.  Randomized evaluation of fibrinogen vs placebo in complex cardiovascular surgery (REPLACE): a double-blind phase III study of haemostatic therapy.

Authors:  N Rahe-Meyer; J H Levy; C D Mazer; A Schramko; A A Klein; R Brat; Y Okita; Y Ueda; D S Schmidt; R Ranganath; R Gill
Journal:  Br J Anaesth       Date:  2016-07       Impact factor: 9.166

4.  Thromboelastometric Monitoring of the Hemostatic Effect of Platelet Concentrates Transfusion in Thrombocytopenic Children Undergoing Chemotherapy.

Authors:  Bernhard Ziegler; Cristina Solomon; Janne Cadamuro; Neil Jones
Journal:  Clin Appl Thromb Hemost       Date:  2014-12-18       Impact factor: 2.389

Review 5.  Perioperatively acquired disorders of coagulation.

Authors:  Oliver Grottke; Dietmar Fries; Bartolomeu Nascimento
Journal:  Curr Opin Anaesthesiol       Date:  2015-04       Impact factor: 2.706

6.  Heparin and Protamine Titration Does Not Improve Haemostasis after Cardiac Surgery: A Prospective Randomized Study.

Authors:  Vladimir Radulovic; Anna Laffin; Kenny M Hansson; Erika Backlund; Fariba Baghaei; Anders Jeppsson
Journal:  PLoS One       Date:  2015-07-02       Impact factor: 3.240

7.  Platelet-dependent thrombography gives a distinct pattern of in vitro thrombin generation after surgery with cardio-pulmonary bypass: potential implications.

Authors:  Rose Said; Véronique Regnault; Marie Hacquard; Jean-Pierre Carteaux; Thomas Lecompte
Journal:  Thromb J       Date:  2012-08-21

8.  Time course of haemostatic effects of fibrinogen concentrate administration in aortic surgery.

Authors:  C Solomon; C Hagl; N Rahe-Meyer
Journal:  Br J Anaesth       Date:  2013-02-06       Impact factor: 9.166

9.  Role of Using a Thromboelastometry-Based Protocol for Transfusion Management in Combined Coronary Artery Bypass Grafting and Valve Surgery: A Randomized Clinical Trail.

Authors:  Elham Khalaf-Adeli; Ali Akbar Pourfathollah; Fereidoon Noohi; Alireza Alizadeh-Ghavidel; Hooman Bakhshandeh-Abkenar; Roshanak Shamriz; Seyed Mostafa Alavi
Journal:  Indian J Hematol Blood Transfus       Date:  2020-11-09       Impact factor: 0.915

Review 10.  Assessing the Methodology for Calculating Platelet Contribution to Clot Strength (Platelet Component) in Thromboelastometry and Thrombelastography.

Authors:  Cristina Solomon; Marco Ranucci; Gerald Hochleitner; Herbert Schöchl; Christoph J Schlimp
Journal:  Anesth Analg       Date:  2015-10       Impact factor: 6.627

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.